Target intelligence / Profile preview

Neuronal regeneration pathways

Molecular classification
Other
01

Overview

"Neuronal regeneration pathways" encompass the diverse signaling systems and transcriptional programs that govern the intrinsic and extrinsic response of neurons to injury, directing axonal regrowth, dendritic plasticity, and, in some cases, neurogenesis. These involve growth factor signaling (e.g., FGF, WNT, PDGF, BDNF), mitogen-activated protein kinase (MAPK) cascades (e.g., JNK, p38), cAMP response elements, PI3K/Akt/mTOR pathway, JAK/STAT signaling, semaphorin-plexin and integrin-mediated networks, and are regulated both at the level of transcription (by factors such as ATF3, KLF family) and cytoskeleton dynamics (through proteins like CRMP2, CLASP, tau). The pathways are targets for modulating repair after central and peripheral nervous system damage, but due to their broad physiological roles, direct pharmacological targeting involves safety concerns such as cancer risk or maladaptive plasticity (e.g., pain syndromes) [1][2][3][4][5][6]. In summary, "Neuronal regeneration pathways" is not a specific, targetable molecule or protein but a conceptual category encompassing a large, complex set of repair-associated signaling mechanisms in the nervous system.

Other names
neural regeneration pathwaysneuronal repair pathwaysaxonal regeneration signalingneurite regeneration mechanisms
02

Mechanism of action

Growth factor receptor agonism (e.g., BDNF/TrkB); MAPK/ERK pathway activation; JAK/STAT pathway activation; PI3K/Akt/mTOR enhancement; RhoA/ROCK inhibition; GSK3β inhibition

03

Biological functions

RegenerationNeurite outgrowthAxonal regrowthNeuronal plasticityNeurogenesis
04

Disease associations

Neurodegenerative diseaseSpinal cord injuryPeripheral nerve injuryNeuropathic painStroke
05

Safety considerations

Oncogenic risk with mTOR activationAberrant plasticity leading to neuropathic painImmune system modulationOff-target CNS effects
06

Interacting drugs

4-Methylhistamine dihydrochloride

4 more in the full profile.

07

Biomarkers

GAP43ATF3TUBB2BSTMN2

Beyond the preview

Go deeper on Neuronal regeneration pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal regeneration pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call